PHF5A promotes colorectal cancerprogression by alternative splicing of TEAD2
Dysregulated alternative splicing (AS) plays critical roles in driving cancer progression, and the underlying mechanisms remain largely unknown. Here, we demonstrated that PHF5A, a component of U2 small nuclear ribonucleoproteins, was frequently upregulated in colorectal cancer (CRC) samples and ass...
Saved in:
Main Authors: | Yue Chang (Author), Yulu Zhao (Author), Liya Wang (Author), Meijuan Wu (Author), Chenglong He (Author), Mengxi Huang (Author), Zengjie Lei (Author), Jiahe Yang (Author), Siqi Han (Author), Bibo Wang (Author), Yanyan Chen (Author), Chao Liu (Author), Hongju Yu (Author), Lijun Xue (Author), Jian Geng (Author), Yanan Chen (Author), Tingting Dai (Author), Lili Ren (Author), Qian Wang (Author), Xiaobei Liu (Author), Xiaoyuan Chu (Author), Cheng Chen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia
by: Hsiang-i Tsai, et al.
Published: (2022) -
Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma
by: Cheol Lee, et al.
Published: (2017) -
Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3
by: Tian Lu, et al.
Published: (2021) -
A Novel Nonsense Mutation of PHF6 in a Female with Extended Phenotypes of Borjeson-Forssman-Lehmann Syndrome
by: Xia Zhang, et al.
Published: (2019) -
Direct YAP/TAZ-TEAD inhibitor paves the way toward realizing cancer mechanomedicine
by: Kostas A. Papavassiliou, et al.
Published: (2024)